AMAG Pharmaceuticals Kiemelkedően
Mi az AMAG Pharmaceuticals Kiemelkedően?
A Kiemelkedően az AMAG Pharmaceuticals, Inc. - 34.725M
Mi a Kiemelkedően meghatározása?
A fennálló részvények egy olyan vállalat vagy pénzügyi eszköz részvényei, amelyeket a befektetők engedélyeztek, bocsátottak ki és vásároltak meg.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Kiemelkedően a Health Care szektor a NASDAQ-on cégekben a AMAG Pharmaceuticals -hoz képest
Mit csinál AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
kiemelkedően -hoz hasonló cégek AMAG Pharmaceuticals
- Star L.P nak Kiemelkedően 34.661M van
- Artemis Alpha Trust plc nak Kiemelkedően 34.663M van
- Universal Cables nak Kiemelkedően 34.695M van
- Universal Cables nak Kiemelkedően 34.695M van
- SMA Solar Technology AG nak Kiemelkedően 34.700M van
- Marine Products Corp nak Kiemelkedően 34.718M van
- AMAG Pharmaceuticals nak Kiemelkedően 34.725M van
- Valhalla Metals nak Kiemelkedően 34.732M van
- AVEO Pharmaceuticals Inc nak Kiemelkedően 34.763M van
- Urban One Inc nak Kiemelkedően 34.773M van
- Watsco nak Kiemelkedően 34.789M van
- Hunter Douglas NV nak Kiemelkedően 34.790M van
- Full House Resorts nak Kiemelkedően 34.800M van